Delivering cancer stem cell therapies – A role for nanomedicines?
- 1 June 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (9) , 1309-1315
- https://doi.org/10.1016/j.ejca.2006.01.044
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dynamics of chronic myeloid leukaemiaNature, 2005
- It's the ecology, stupid!Nature, 2005
- Leukaemia stem cells and the evolution of cancer-stem-cell researchNature Reviews Cancer, 2005
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Tumour-targeted drug and gene delivery: principles and conceptsExpert Reviews in Molecular Medicine, 2004
- Therapeutic implications of cancer stem cellsCurrent Opinion in Genetics & Development, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Putting tumours in contextNature Reviews Cancer, 2001
- Resistance mechanisms associated with altered intracellular distribution of anticancer agentsPharmacology & Therapeutics, 2000
- HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell lineJournal of Controlled Release, 1998